RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

raloxifene hydrochloride, Quantity: 60 mg

Prieinama:

MedTAS Pty Ltd

INN (Tarptautinis Pavadinimas):

Raloxifene hydrochloride

Vaisto forma:

Tablet, film coated

Sudėtis:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Vartojimo būdas:

Oral

Vienetai pakuotėje:

28 tablets

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Produkto santrauka:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Licence status A

Leidimo data:

2014-01-14